196 related articles for article (PubMed ID: 25605945)
1. The first step of peptide selection in antigen presentation by MHC class I molecules.
Garstka MA; Fish A; Celie PH; Joosten RP; Janssen GM; Berlin I; Hoppes R; Stadnik M; Janssen L; Ovaa H; van Veelen PA; Perrakis A; Neefjes J
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1505-10. PubMed ID: 25605945
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.
Persson K; Schneider G
Arch Immunol Ther Exp (Warsz); 2000; 48(3):135-42. PubMed ID: 10912617
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of MHC class I molecules with bound peptide antigens.
Wilson IA; Fremont DH
Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
[TBL] [Abstract][Full Text] [Related]
4. pH dependence of MHC class I-restricted peptide presentation.
Stryhn A; Pedersen LO; Romme T; Olsen AC; Nissen MH; Thorpe CJ; Buus S
J Immunol; 1996 Jun; 156(11):4191-7. PubMed ID: 8666787
[TBL] [Abstract][Full Text] [Related]
5. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
Zhang C; Anderson A; DeLisi C
J Mol Biol; 1998 Sep; 281(5):929-47. PubMed ID: 9719645
[TBL] [Abstract][Full Text] [Related]
6. MHC class I/peptide interactions: binding specificity and kinetics.
Margulies DH; Corr M; Boyd LF; Khilko SN
J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
[TBL] [Abstract][Full Text] [Related]
7. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
[TBL] [Abstract][Full Text] [Related]
8. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
[TBL] [Abstract][Full Text] [Related]
9. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
Adams S; Humphreys RE
Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
[TBL] [Abstract][Full Text] [Related]
10. Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity.
Harndahl M; Rasmussen M; Roder G; Dalgaard Pedersen I; Sørensen M; Nielsen M; Buus S
Eur J Immunol; 2012 Jun; 42(6):1405-16. PubMed ID: 22678897
[TBL] [Abstract][Full Text] [Related]
11. Characterization of MHC/peptide complexes refolded by a one-step ion-exchange chromatography.
Shen C; He Y; Meng F; Cheng K; Zhang D; Miao F; Zhang J
J Immunol Methods; 2011 Jun; 369(1-2):81-90. PubMed ID: 21620853
[TBL] [Abstract][Full Text] [Related]
12. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
13. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
Bordner AJ; Abagyan R
Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
[TBL] [Abstract][Full Text] [Related]
14. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
15. Interactions between immunogenic peptides and MHC proteins.
Rothbard JB; Gefter ML
Annu Rev Immunol; 1991; 9():527-65. PubMed ID: 1910688
[TBL] [Abstract][Full Text] [Related]
16. Noncanonical peptides in complex with MHC class I.
Apostolopoulos V; Lazoura E
Expert Rev Vaccines; 2004 Apr; 3(2):151-62. PubMed ID: 15056041
[TBL] [Abstract][Full Text] [Related]
17. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
18. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation.
Young AC; Nathenson SG; Sacchettini JC
FASEB J; 1995 Jan; 9(1):26-36. PubMed ID: 7821756
[TBL] [Abstract][Full Text] [Related]
20. Statistical deconvolution of enthalpic energetic contributions to MHC-peptide binding affinity.
Davies MN; Hattotuwagama CK; Moss DS; Drew MG; Flower DR
BMC Struct Biol; 2006 Mar; 6():5. PubMed ID: 16549002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
